Latest Breaking News On - Exchange offer on - Page 1 : vimarsana.com
By Notice of Repurchase Offer dated March 25, 2021 (the
Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the
2017/22 Bonds) on the terms set out in the Notice (the
Exchange
Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation.
S
ettlement
Santhera has decided to settle the Exchange Offer on May 4, 2021. The Exchange Offer will be settled via the banking system. Upon settlement, all offer conditions (b), (c), (d) and (e), as set out in the Notice, which have not been satisfied until that date will be waived.
PrattelnSwitzerland-generalSwitzerlandUnited-statesUnited-kingdomAmericanSwissEva-kaliasSanthera-pharmaceuticalsSwiss-financial-services-act-finHead-external-communicationsFinancial-servicesBy Notice of Repurchase Offer dated March 25, 2021 (the
Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the
2017/22 Bonds) on the terms set out in the Notice (the
Exchange
Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation.
S
ettlement
Santhera has decided to settle the Exchange Offer on May 4, 2021. The Exchange Offer will be settled via the banking system. Upon settlement, all offer conditions (b), (c), (d) and (e), as set out in the Notice, which have not been satisfied until that date will be waived.
PrattelnSwitzerland-generalSwitzerlandUnited-statesUnited-kingdomAmericanSwissEva-kaliasSanthera-pharmaceuticalsSwiss-financial-services-act-finHead-external-communicationsFinancial-services